Campbell & Co Investment Adviser’s Health Catalyst HCAT Stock Holding History

Campbell & Co Investment Adviser’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,051	Closed	-$162K	–	1215
2025 Q2	$162K	Buy	43,051 +3,808	+10%	+$15K	0.01%	1079
2025 Q1	$178K	Sell	39,243 -4,012	-9%	-$21.2K	0.01%	957
2024 Q4	$306K	Sell	43,255 -16,091	-27%	-$128K	0.02%	844
2024 Q3	$483K	Sell	59,346 -5,164	-8%	-$37.3K	0.04%	734
2024 Q2	$412K	Buy	64,510 +42,686	+196%	+$274K	0.04%	721
2024 Q1	$164K	Buy	+21,824	New	+$199K	0.01%	1034

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Campbell & Co Investment Adviser's HCAT Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 43,051 shares — an estimated $162K sold.

Campbell & Co Investment Adviser first reported a position in HCAT in Q1 2024 and held it in 6 quarters. The position peaked at $483K in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

Campbell & Co Investment Adviser reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
Campbell & Co Investment Adviser sold 43,051 Health Catalyst shares in Q3 2025, an estimated $162K.
Campbell & Co Investment Adviser first reported a position in Health Catalyst in Q1 2024 and held it in 6 quarters.
Campbell & Co Investment Adviser's Health Catalyst position peaked at $483K in Q3 2024.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.